<DOC>
	<DOCNO>NCT00043225</DOCNO>
	<brief_summary>This study examine 1 ) role hereditary factor cystic fibrosis ; i.e. , relationship disease specific gene variation , 2 ) role bacterial product involve lung infection substance produce bacteria may worsen disease . Patients cystic fibrosis follow Medical College Wisconsin University Wisconsin-Madison eligible study . Participants blood test , pulmonary function test , sputum culture , buccal swabbing ( cotton swab inside cheek collect cell DNA study ) . In addition , medical record review history lung infection result various test , include pulmonary function study , chest X-rays bacterial culture . Blood sample collect previously Medical College Wisconsin University Wisconsin-Madison also analyze antibody bacteria . Although one-time study , participant may ask return repeat test .</brief_summary>
	<brief_title>The Role Bacteria Genetic Variations Cystic Fibrosis</brief_title>
	<detailed_description>Individuals cystic fibrosis ( CF ) susceptible chronic bacterial colonization Pseudomonas aeruginosa , result deterioration lung function , eventually , death . In study , hope improve understand innate immune response infection strain P. aeruginosa express type III cytotoxins delineate good role modifier gene disease progression . We examine relationships patient 's clinical course , presence antibody P. aeruginosa , single nucleotide polymorphism suspect CF modifier gene .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>INCLUSION CRITERIA : Patients cystic fibrosis define mutation CFTR ( e.g. , known variant CFTR gene , delta F508 allele ) bear state Wisconsin since 1985 otherwise follow cystic fibrosis center Medical College Wisconsin University WisconsinMadison . Patients test tested CFTR gene another protocol ( 96H0100 ) . Patients may colonize P. aeruginosa organism ( e.g. , Burkholderia cepacia ) . The age range NIH participant study 9 80 year old . EXCLUSION CRITERIA : There exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2, 2016</verification_date>
	<keyword>Type III Secretion Pathways</keyword>
	<keyword>Exotoxin A Polymorphisms</keyword>
	<keyword>Cystic Fibrosis Pseudomonas Aeruginosa</keyword>
	<keyword>Adenosine Deaminase Deficiency</keyword>
	<keyword>Severe Combined Immune Deficiency</keyword>
	<keyword>SCID</keyword>
	<keyword>ADA-SCID</keyword>
	<keyword>Immune Deficiency</keyword>
</DOC>